The deal size was increased to $300M from $250M. Goldman Sachs, BofA, Jefferies and Barclays are acting as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on FDMT:
- 4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
- 4D Molecular files automatic mixed securities shelf
- 4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
- 4D Molecular announces $250M common stock offering
- 4D Molecular files to sell $250M in common stock